Senda Ajroud-Driss – Grants — Northwestern Scholars

View Scopus Profile

Emails-ajroudnorthwesternedu

h-index
h10-index
h5-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

27 Finished
36 Active

1 - 25 out of 63 results

Research project

Prot# VMDN-001: A Phase I/II Open Label, Dose-Escalation Study to Assess the Safety and Tolerability of VM202 in Patients with Painful Diabetic Peripheral Neuropathy
Kessler, J. & Ajroud-Driss, S.
ViroMed Co., Ltd.
2/22/10 → 2/21/13
Project: Research project
HDE Post-Approval Study (PAS) of NeuRx DPS™ for ALS
Wolfe, L. F., Ajroud-Driss, S., Hungness, E. & Sufit, R. L.
Synapse Biomedical, Inc.
10/4/12 → 10/4/18
Project: Research project
Prot# 3119003: Effects of Oral Levosimendan(ODM-109) on Respiratory Funcation in Patients with ALS: Open-Label Extension for Patients Completing Study 3119002
Ajroud-Driss, S.
Pharmaceutical Research Associates, Inc., Orion Group
7/19/19 → 7/19/22
Project: Research project
Prot# 233AS102: An Extension Study to Assess the Long-Term Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB067 Administered to Previously Treated Adults with Amyotrophic Lateral Sclerosis Caused by Superoxide Dismutase 1 M
Ajroud-Driss, S.
Quintiles, Inc., Biogen MA Inc.
11/24/20 → 11/24/23
Project: Research project
Emerging Real-World Use of Nusinersen in Adult Patients with Spinal Muscular Atrophy (SMA) in the US: A Multi-Site Chart Review Study
Ajroud-Driss, S.
Analytica La-Ser International, Inc., Biogen Inc.
7/6/20 → 7/6/23
Project: Research project
Cost Reimbursement
Ajroud-Driss, S.
Massachusetts General Hospital
3/23/20 → 12/31/22
Project: Research project
HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) D to Master Protocol Pridopidine | Double-Blind Phase
Ajroud-Driss, S.
Massachusetts General Hospital
11/20/20 → 11/19/22
Project: Research project
Answer ALS: Individualized Initiative for ALS Discovery
Ajroud-Driss, S.
Johns Hopkins University, Les Turner Amyotrophic Lateral Sclerosis Foundation, Ltd.
1/1/18 → 12/31/21
Project: Research project
HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) A to Master Protocol ZILUCOPLAN | Home Spirometry and Open-Label Extension (OLE) Period
Ajroud-Driss, S.
Massachusetts General Hospital, Ra Pharmaceuticals, Inc.
3/15/21 → 3/14/23
Project: Research project
HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) C to Master Protocol CNM-Au8 | Double-Blind Phase
Ajroud-Driss, S.
Massachusetts General Hospital
3/23/20 → 12/31/22
Project: Research project
Master Clinical Trial Agreement - HEALEY ALS Platform Trial
Ajroud-Driss, S.
Massachusetts General Hospital
12/5/19 → 12/4/24
Project: Research project
Prot # VMDN-002/C: A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects with Painful Diabetic Peripheral Neuropathy
Ajroud-Driss, S. & Sufit, R. L.
ViroMed Co., Ltd.
11/2/12 → 11/2/15
Project: Research project
HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) D to Master Protocol PRIDOPIDINE | Home Spirometry and Open-Label Extension (OLE) Period
Ajroud-Driss, S.
Massachusetts General Hospital, Prilenia Neurotherapeutics Ltd
9/4/20 → 3/14/23
Project: Research project
Prot# ALN-TTRSC02-002: HELIOS-A: A Phase 3 Global, Randomized, Open-label Study to Evaluate the Efficacy and Safety of ALN-TTRSC02 in Patients with Hereditary Transthyretin Amyloidosis(hATTR Amyloidosis)
Ajroud-Driss, S.
Medpace, Inc., Alnylam Pharmaceuticals, Inc.
2/22/19 → 2/24/23
Project: Research project
Neuroimaging Symposium in ALS
Ajroud-Driss, S.
ViroMed Co., Ltd.
8/1/15 → 7/31/16
Project: Research project
Prot# VMALS-002-2: A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants with Amyotrophic Lateral Sclerosis
Ajroud-Driss, S.
Worldwide Clinical Trials, Inc., ViroMed Co., Ltd.
4/29/21 → 4/29/24
Project: Research project
Prot#US-SPN-17-11267: A Prospective, Multi-center, Open-Label, Observational Study of the Safety, Tolerability and Effectiveness of SPINRAZA in Adults with SMA
Ajroud-Driss, S.
Washington University St. Louis, Biogen Inc.
5/14/20 → 5/14/23
Project: Research project
Prot#AB19001: A Prospective, Multicenter, Randomised, Double-Blind, Placebo-Controlled, Parallel Groups, Phase 3 Study to Compare the Efficacy and Safety of Masitinib in Combination with Riluzole Versus Placebo in Combination with Riluzole in the Treatmen
Ajroud-Driss, S.
AB Science
2/26/21 → 2/26/24
Project: Research project
HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) E to Master Protocol TREHALOSE S-005
Ajroud-Driss, S.
Massachusetts General Hospital, NexMed, Inc.
3/1/22 → 12/4/24
Project: Research project
Prot:ALXN1210-MG-306: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Naïve Adult Patients With Generalized Myasthenia Gravis
Ajroud-Driss, S.
INC Research, LLC, Alexion Pharmaceuticals, Inc.
1/17/20 → 1/17/23
Project: Research project
Prot# 07-AVR-123: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy and to Determine the Pharmacokinetics of Two Doses of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Pseudobulbar Affect (PBA)
Sufit, R. L. & Ajroud-Driss, S.
Kendle International Inc., Avanir Pharmaceuticals
4/10/08 → 4/10/11
Project: Research project
International GBS Outcome Study (IGOS)
Ajroud-Driss, S.
GBS/CIDP Foundation International, Inc.
3/1/13 → 2/28/18
Project: Research project
Lois Insolia ALS Center
Siddique, T., Sufit, R. L., Ajroud-Driss, S., Siddique, T., Wolfe, L. F. & Coleman III, J. M.
Les Turner Amyotrophic Lateral Sclerosis Foundation, Ltd.
1/1/99 → 12/31/15
Project: Research project
I AM ALS: Expanded Access Protocol (EAP) Program Proposal
Ajroud-Driss, S.
Massachusetts General Hospital, I AM ALS
9/3/21 → 12/31/22
Project: Research project
UMMS-ASO-STMN2 Study
Ajroud-Driss, S.
Hopewell Fund
11/1/21 → 10/31/22
Project: Research project